Showing results (3441-3450 of 8,680) with videos related to

Sort By:
Pageof 868
Bioorganic Chemistry|March 18, 2017
The first synthesis of 4-phenylbutenone derivative bromophenols including natural products and their inhibition profiles for carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase enzymesÇetin Bayrak, Parham Taslimi, İlhami Gülçin, et al.
Bioorganic Chemistry|May 14, 2014
Design, synthesis and biological evaluation of novel thiosemicarbazide analogues as potent anticonvulsant agentsReshma J Nevagi, Avinash S Dhake, Harsha I Narkhede, et al.
Bioorganic Chemistry|March 27, 2019
Synthesis, molecular docking studies, and antimicrobial evaluation of new structurally diverse ureasMahadev Patil, Anurag Noonikara Poyil, Shrinivas D Joshi, et al.
Bioorganic Chemistry|March 30, 2019
Bioactive terpenoids from Euonymus verrucosus var. pauciflorus showing NO inhibitory activitiesYuling Yang, Xueyuan Yang, Xuke Zhang, et al.
Bioorganic Chemistry|April 1, 2019
Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromeneFawzia F Alblewi, Rawda M Okasha, Zainab M Hritani, et al.
Bioorganic Chemistry|February 26, 2021
Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimicsHao Li, Peter Illés, Chamini V Karunaratne, et al.
Bioorganic Chemistry|February 25, 2021
Synthesis of 4,6-diphenylpyrimidin-2-ol derivatives as new benzodiazepine receptor ligandsMona Khoramjouy, Elham Rezaee, Afshan Khoshnevis, et al.
Bioorganic Chemistry|February 27, 2021
Preclinical assessment of stem of Nicotiana tabacum on excision wound modelYash Sharma, Amritpal Kaur, Rohit Bhardwaj, et al.
Bioorganic Chemistry|February 28, 2021
Design, synthesis and biological evaluations of diverse Michael acceptor-based phenazine hybrid molecules as TrxR1 inhibitorsYucheng Zhong, Jing Liu, Xiangyu Cheng, et al.
Bioorganic Chemistry|February 28, 2021
Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's diseaseLi Liu, Yi Chen, Rui-Feng Zeng, et al.
Pageof 868